Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tristan J, King"'
Autor:
Bruce K. Foster, Ke Ming Chen, Tristan J. King, Cory J. Xian, Peter R. C. Howe, Alice M. C. Lee, Tetyana Shandala
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 8, Pp 18293-18311 (2015)
International Journal of Molecular Sciences
Volume 16
Issue 8
Pages 18293-18311
International Journal of Molecular Sciences
Volume 16
Issue 8
Pages 18293-18311
Chemotherapy-induced bone damage is a frequent side effect which causes diminished bone mineral density and fracture in childhood cancer sufferers and survivors. The intensified use of anti-metabolite methotrexate (MTX) and other cytotoxic drugs has
Autor:
Kristen Georgiou, Hong Zhou, Cory J. Xian, Bruce K. Foster, Michaela Scherer, Tristan J. King
Publikováno v:
Bone. 50:1223-1233
Cancer chemotherapy often causes significant bone loss, marrow adiposity and haematopoietic defects, yet the underlying mechanisms and recovery potential remain unclear. Wnt/β-catenin signalling is integral to the regulation of osteogenesis, adipoge
Publikováno v:
International Journal of Experimental Pathology. 93:104-114
Cancer chemotherapy disrupts the bone marrow (BM) microenvironment affecting steady-state proliferation, differentiation and maintenance of haematopoietic (HSC) and stromal stem and progenitor cells; yet the underlying mechanisms and recovery potenti
Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow
Autor:
Michaela Scherer, Kristen Georgiou, Johanna C. Cool, Tristan J. King, Chiaming Fan, Cory J. Xian, Bruce K. Foster
Publikováno v:
Journal of Cellular Physiology. 227:909-918
Intensive use of cancer chemotherapy is increasingly linked with long-term skeletal side effects such as osteopenia, osteoporosis and fractures. However, cellular mechanisms by which chemotherapy affects bone integrity remain unclear. Methotrexate (M
Publikováno v:
International journal of experimental pathology. 93(2)
Cancer chemotherapy disrupts the bone marrow (BM) microenvironment affecting steady-state proliferation, differentiation and maintenance of haematopoietic (HSC) and stromal stem and progenitor cells; yet the underlying mechanisms and recovery potenti
Publikováno v:
Journal of Biomedicine and Biotechnology, Vol 2011 (2011)
Journal of Biomedicine and Biotechnology
Journal of Biomedicine and Biotechnology
The advancement and intensive use of chemotherapy in treating childhood cancers has led to a growing population of young cancer survivors who face increased bone health risks. However, the underlying mechanisms for chemotherapy-induced skeletal defec
Autor:
Yeap Ng, Tetyana Shandala, Yin-chin Yip, Tristan J. King, Blair Hopwood, Bruce K. Foster, Chiaming Fan, Cory J. Xian
Publikováno v:
Bone. 47:S40-S41
Publikováno v:
Bone. 48:S258
The chemotherapeutic agent methotrexate (MTX), commonly used to treat a variety of cancers, has been shown to cause bone defects including osteoporosis. To investigate the underlying pathophysiology using a rat model, the current study sought to char
Autor:
Cory J. Xian, Chiaming Fan, Bruce K. Foster, Blair Hopwood, Yeap Ng, Tristan J. King, Kristen Georgiou, Michaela Scherer, Tetyana Shandala
Publikováno v:
Bone. 48:S247
Autor:
Kristen Georgiou, Yeap Ng, Tristan J. King, Jo Cool, Yin-chin Yip, Michaela Scherer, Tetyana Shandala, Blair Hopwood, Chiaming Fan, Bruce K. Foster, Cory J. Xian
Publikováno v:
Bone. 47:S388